Search Share Prices
AZN Shares - AstraZeneca drug for chronic lymphocytic leukaemia successfully navigates phase III trial
An AstraZeneca PLC (LON:AZN) drug being developed chronic lymphocytic leukaemia has successfully navigated a phase III clinical trial. AZ’s Calquence, to use the jargon, demonstrated a ...
FTSE 100 back on level pegging
Footsie winners were in short supply and not even a decent set of results from a Phase III trial of a cancer treatment, Lynparza, developed with US drugs giant Merck could lift AstraZeneca PLC ...
Starpharma Signs Second Oncology Agreement With AstraZeneca
MELBOURNE, Australia--(Business Wire)--Starpharma (ASX: SPL, OTCQX: SPHRY) today announced a Development and Option Agreement with AstraZeneca (LON: AZN) to progress the development of a Dendrimer ...
The Astrazeneca share price – where next?
The Astrazeneca (LON:AZN) share price has risen by 2.12% over the past month and it’s currently trading at 6028p. For investors considering whether to buy, hold or sell the stock, the question now is ...
Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC
StockMarketWire.com - Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC [LON:AZN] and cut its price target to 6350p (from 6400p). ...